Text Size

Research Progress - All Articles


Spotlight on Research: Dr. Alfredo Dubra's Laboratory at Stanford

Adaptive optics is a technology that was originally proposed to look at the stars. We are using the same technology and applying it to the eye, to capture sharp images of the retina.

Read More »

Catalyst for a Cure Biomarker Initiative: A Game Changer in the Fight to Protect Vision

Investigators with the Catalyst for a Cure Biomarker Initiative are on the verge of identifying new biological markers that can provide physicians with better tools to diagnose and manage glaucoma before vision is lost.

Read More »

2017 Research Grants

Glaucoma Research Foundation provides seed money for creative pilot research projects that hold promise. Read about the 2017 research grants to explore new ideas.

Read More »

Biomarkers and Drug Discovery: Jeffrey L. Goldberg, MD, PhD

Jeffrey L. Goldberg, MD, PhD (Professor and Chair, Department of Ophthalmology, Stanford University School of Medicine) presented research advances from the Catalyst for a Cure biomarkers team at the Glaucoma 360 New Horizons Forum on February 3, 2017 in...

Read More »

Video: Dr. Larry Benowitz discusses Optic Nerve Regeneration

In this video interview, Dr. Larry Benowitz (Harvard Medical School) discusses how far the field of optic nerve regeneration has come in the past 10 years.

Read More »

Glaucoma Market Sees Raft of Hot New Tech

Kicking off the sixth annual Glaucoma 360 - New Horizons Forum, co-founder and co-chair Adrienne Graves, PhD proclaimed that “glaucoma is hot.”

Read More »

Catalyst for a Cure: 2017 Research Progress

The Catalyst for a Cure Biomarker Initiative funded by Glaucoma Research Foundation is a collaborative research effort designed to accelerate the pace of discovery toward better treatments and ultimately a cure for glaucoma.

Read More »

Glaucoma Biomarkers - from the Laboratory to the Clinic

During the past year, the Catalyst for a Cure researchers have been taking necessary steps to move their studies from the laboratory to the clinic. This will be an exciting and important next step to further test and evaluate a new glaucoma biomarker.

Read More »

Saving Sight in Glaucoma: Why the Brain May Hold the Key

What causes vision loss in glaucoma? There are two common answers: the first is elevated ocular pressure, and the second is damage to the optic nerve.

Read More »

President's Report from ARVO 2016

GRF President and CEO Thomas M. Brunner reports on the state of glaucoma research from the 2016 ARVO meeting that took place in Seattle.

Read More »